These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

892 related articles for article (PubMed ID: 33981029)

  • 21. COVID 19: Diabetes and Obesity API-ICP Recommendations.
    Joshi SR; Tiwaskar MH; Shah SN
    J Assoc Physicians India; 2020 May; 68(5):42-44. PubMed ID: 32610865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report.
    Jornayvaz FR; Assouline B; Pugin J; Gariani K
    BMC Endocr Disord; 2020 Oct; 20(1):155. PubMed ID: 33066762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetes Mellitus and COVID-19: Review Article.
    Nassar M; Daoud A; Nso N; Medina L; Ghernautan V; Bhangoo H; Nyein A; Mohamed M; Alqassieh A; Soliman K; Alfishawy M; Sachmechi I; Misra A
    Diabetes Metab Syndr; 2021; 15(6):102268. PubMed ID: 34562865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is metformin a miracle or a menace in COVID-19 patients with type 2 diabetes?
    Lui DTW; Tan KCB
    J Diabetes Investig; 2021 Apr; 12(4):479-481. PubMed ID: 33331120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9).
    Rhee SY
    Diabetes Metab J; 2021 Jul; 45(4):619-620. PubMed ID: 34352992
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9).
    Schernthaner G
    Diabetes Metab J; 2021 Jul; 45(4):615-616. PubMed ID: 34352990
    [No Abstract]   [Full Text] [Related]  

  • 27. Glucose-lowering drugs and outcome from COVID-19 among patients with type 2 diabetes mellitus: a population-wide analysis in Hong Kong.
    Luk AOY; Yip TCF; Zhang X; Kong APS; Wong VW; Ma RCW; Wong GL
    BMJ Open; 2021 Oct; 11(10):e052310. PubMed ID: 34670765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remote Glucose Monitoring Platform for Multiple Simultaneous Patients at Coronavirus Disease 2019 Intensive Care Units: Case Report Including Adults and Children.
    Garelli F; Rosales N; Fushimi E; Arambarri D; Mendoza L; De Battista H; Sánchez-Peña R; García Arabehety J; Distefano S; Barcala C; Giunta J; Las Heras M; Martinez Mateu C; Prieto M; San Román E; Krochik G; Grosembacher L
    Diabetes Technol Ther; 2021 Jun; 23(6):471-473. PubMed ID: 33337261
    [No Abstract]   [Full Text] [Related]  

  • 29. COVID-19 vaccination in adolescents and young adults with type 1 diabetes: Glycemic control and side effects.
    Piccini B; Pessina B; Pezzoli F; Casalini E; Toni S
    Pediatr Diabetes; 2022 Jun; 23(4):469-472. PubMed ID: 35150596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of intensive glucose lowering in treatment of type 2 diabetes mellitus on cardiovascular outcomes: A meta-analysis of data from 58,160 patients in 13 randomized controlled trials.
    Fang HJ; Zhou YH; Tian YJ; Du HY; Sun YX; Zhong LY
    Int J Cardiol; 2016 Sep; 218():50-58. PubMed ID: 27236108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: A multicentral retrospective study.
    Cheng X; Xin S; Chen Y; Li L; Chen W; Li W; Zhou B; Li C; Gong Y; Li F; Duan P; Zhou X
    Life Sci; 2021 Jun; 275():119371. PubMed ID: 33745895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Outcomes of Remote Training for Advanced Diabetes Technologies During the COVID-19 Pandemic.
    Bozzetto L; De Angelis R; Calabrese I; Giglio C; Annuzzi G
    J Diabetes Sci Technol; 2022 Jan; 16(1):264-265. PubMed ID: 34632815
    [No Abstract]   [Full Text] [Related]  

  • 33. Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies.
    Longo M; Caruso P; Maiorino MI; Bellastella G; Giugliano D; Esposito K
    Cardiovasc Diabetol; 2020 Jul; 19(1):115. PubMed ID: 32698837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis of the hallmark cardiovascular and renal outcome trials addressing the risk for respiratory tract infections with sodium-glucose co-transporter-2 inhibitors: Implications for the COVID-19 pandemic.
    Patoulias D; Papadopoulos C; Boulmpou A; Doumas M
    Diabetes Obes Metab; 2021 Jul; 23(7):1696-1700. PubMed ID: 33606909
    [No Abstract]   [Full Text] [Related]  

  • 35. EMPA-REG and Other Cardiovascular Outcome Trials of Glucose-lowering Agents: Implications for Future Treatment Strategies in Type 2 Diabetes Mellitus.
    Schernthaner G; Schernthaner-Reiter MH; Schernthaner GH
    Clin Ther; 2016 Jun; 38(6):1288-1298. PubMed ID: 27210264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Continuing or stopping metformin in patients with type 2 diabetes exposed to SARS-CoV-2 ?].
    Scheen AJ; Paquot N
    Rev Med Liege; 2021 Mar; 76(3):152-155. PubMed ID: 33682382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does lowering of blood glucose improve cardiovascular morbidity and mortality?
    Iqbal N; Rubenstein AH
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):163-7. PubMed ID: 18178783
    [No Abstract]   [Full Text] [Related]  

  • 38. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes.
    Zhu L; She ZG; Cheng X; Qin JJ; Zhang XJ; Cai J; Lei F; Wang H; Xie J; Wang W; Li H; Zhang P; Song X; Chen X; Xiang M; Zhang C; Bai L; Xiang D; Chen MM; Liu Y; Yan Y; Liu M; Mao W; Zou J; Liu L; Chen G; Luo P; Xiao B; Zhang C; Zhang Z; Lu Z; Wang J; Lu H; Xia X; Wang D; Liao X; Peng G; Ye P; Yang J; Yuan Y; Huang X; Guo J; Zhang BH; Li H
    Cell Metab; 2020 Jun; 31(6):1068-1077.e3. PubMed ID: 32369736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of Metformin in Patients With Type 2 Diabetes With COVID-19: A Preliminary Retrospective Report.
    Gao Y; Liu T; Zhong W; Liu R; Zhou H; Huang W; Zhang W
    Clin Transl Sci; 2020 Nov; 13(6):1055-1059. PubMed ID: 32955785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of antidiabetic drugs on the incidence of macrovascular complications and mortality in type 2 diabetes mellitus: a new perspective on sodium-glucose co-transporter 2 inhibitors.
    Rahelić D; Javor E; Lucijanić T; Skelin M
    Ann Med; 2017 Feb; 49(1):51-62. PubMed ID: 27535028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.